References
- Shirke MM, Shaikh SA, Harky A. Tele-oncology in the COVID-19 Era: the way forward? Trends Cancer. 2020;6(7):547–549.
- Barber TM. COVID-19 and diabetes mellitus: implications for prognosis and clinical management. Expert Rev Endocrinol Metab. 2020;15(4):227–236.
- Hall JA, Horgan TG, Murphy NA. Nonverbal Communication. Annu Rev Psychol. 2019;70:271–294.
- Harper KJ, Osborn CY, Mayberry LS. Patient-perceived family stigma of Type 2 diabetes and its consequences. Fam Syst Health. 2018;36(1):113–117.
- Rose KJ, Scibilia R. The COVID19 pandemic - Perspectives from people living with diabetes. Diabetes Res Clin Pract. 2021;173:108343.
- Dunbar RI. The social brain hypothesis and its implications for social evolution. Ann Hum Biol. 2009;36(5):562–572.
- Iturralde E, Rausch JR, Weissberg-Benchell J, et al. Diabetes-related emotional distress over time. Pediatrics. 2019;143:6.
- Huang YT, Lee YC, Hsiao CJ. Hospitalization for ambulatory-care-sensitive conditions in Taiwan following the SARS outbreak: a population-based interrupted time series study. J Formos Med Assoc. 2009;108(5):386–394.
- Weickert MO, Robbins T, Kyrou I, et al. Impact of the COVID-19 pandemic on neuroendocrine tumour services in England. Endocrine. 2021;71(1):14–19.
- Pranata R, Henrina J, Raffaello WM, et al. Diabetes and COVID-19: the past, the present, and the future. Metabolism. 2021;121:154814.